ACR 36: Colorectal Cancer Awareness Month.
- Session Year: 2017-2018
- House: Assembly
- Latest Version Date: 2017-04-26
This bill would designate March 2017 as Colorectal Cancer Awareness Month.
This bill would designate March 2017 as Colorectal Cancer Awareness Month.
This bill would designate March 2017 as Colorectal Cancer Awareness Month.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,033 new cases and 5,157 deaths observed in 2013; and
WHEREAS, Colorectal cancer is treatable, curable, and in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2014, only 55 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests (FOBT)/fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 42 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believe that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2017 as Colorectal Cancer Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,033 new cases and 5,157 deaths observed in 2013; and
WHEREAS, Colorectal cancer is treatable, curable, and in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2014, only 55 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests (FOBT)/fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 42 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believe that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2017 as Colorectal Cancer Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,033 new cases and 5,157 deaths observed in 2013; and
WHEREAS, Colorectal cancer is treatable, curable, and in many cases, completely preventable; and
WHEREAS, When colorectal cancers are detected at an early stage, the survival rate is 92 percent; and
WHEREAS, Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease; and
WHEREAS, With proper screening, colorectal cancer can be prevented or, if found early, treated and cured; and
WHEREAS, In 2014, only 55 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test (FOBT) to screen for colorectal cancer; and
WHEREAS, According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests (FOBT)/fecal immunochemical tests (FIT), could reduce death rates of colon cancer up to 66 percent; and
WHEREAS, According to the American Cancer Society, in 2013, only about 42 percent of colorectal cancers were diagnosed at an early, more treatable and curable stage; and
WHEREAS, The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent; and
WHEREAS, Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening; and
WHEREAS, African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country; and
WHEREAS, In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women; and
WHEREAS, The California Colorectal Cancer Coalition (C4) is a nonprofit organization established to increase colorectal cancer screening rates in an effort to decrease mortality associated with the disease, and to implement strategies to reduce disparities in colorectal cancer screening, diagnosis, and treatment among underserved populations in California; and
WHEREAS, The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem; and
WHEREAS, C4 and ACS CAN encourage Californians to discuss the colorectal cancer screening test that is best for them with their doctors and believe that the best test is the one you have done now; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates the month of March 2017 as Colorectal Cancer Awareness Month; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Apr 26, 2017 | Chaptered by Secretary of State - Res. Chapter 36, Statutes of 2017. |
| Apr 26, 2017 | Enrolled and filed with the Secretary of State at 2:35 p.m. |
| Apr 24, 2017 | In Assembly. Ordered to Engrossing and Enrolling. |
| Apr 24, 2017 | Adopted and to Assembly. (Ayes 37. Noes 0. Page 804.) |
| Apr 19, 2017 | Ordered to special consent calendar. |
| Apr 6, 2017 | From committee: Ordered to third reading. |
| Apr 3, 2017 | In Senate. To Com. on RLS. |
| Mar 30, 2017 | Coauthors revised. |
| Mar 27, 2017 | From committee: Be adopted. Ordered to Third Reading. (Ayes 11. Noes 0.) (March 27). |
| Mar 20, 2017 | Referred to Com. on RLS. |
| Mar 16, 2017 | From printer. |
| Mar 15, 2017 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Apr 24, 2017 | Special Consent Calendar # ACR36 | Senate Floor |
Passed |
|
| Mar 27, 2017 | Be adopted. To third reading. | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | ACR 36 |
THIRD READING
Bill No: ACR 36
Introduced: 3/15/17
ASSEMBLY FLOOR: Read and adopted, 3/30/17
SUBJECT: Colorectal Cancer Awareness Month
DIGEST:
This resolution designates March 2017 as Colorectal Cancer Awareness Month.
ANALYSIS: This resolution makes the following legislative findings:
- Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,033 new cases and 5,157 deaths observed in 2013.
- Colorectal cancer is treatable, curable, and in many cases, completely preventable.
- Colorectal cancer is known as a silent killer because symptoms only show up in the later stages of the disease.
- With proper screening, colorectal cancer can be prevented or, if found early, treated and cured.
- According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests/fecal immunochemical tests, could reduce death rates of colon cancer up to 66 percent.
- Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost effective than breast or prostate cancer screening.
- In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women. African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country.
This resolution designates the month of March 2017 as Colorectal Cancer Awareness Month.
Related/Prior Legislation
SCR 118 (Glazer, Resolution Chapter 138, Statutes of 2016) designated March 2016 as Colorectal Cancer Awareness Month.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
AFSCME, AFL-CIO
American Cancer Society
California Colorectal Cancer Coalition
None received
Prepared by: Karen Chow / SFA / (916) 651-1520
4/10/17 10:23:08
**** END ****
ASSEMBLY THIRD READING
ATR Bill Id:ACR 36
Author:(Levine)
As Introduced Ver:March 15, 2017
Majority vote
Committee | Votes | Ayes | Noes |
Rules | 11-0 | Cooley, Cunningham, Berman, Brough, Cervantes, Chen, Friedman, Grayson, Levine, Nazarian, Waldron |
SUMMARY: Designates March 2017 as Colorectal Cancer Awareness Month. Specifically, this resolution makes the following legislative findings:
- Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,033 new cases and 5,157 deaths observed in 2013. With proper screening, colorectal cancer can be prevented or, if found early, treated and cured.
- According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests, could reduce death rates of colon cancer up to 66%.
- In 2014, only 55% of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19% had received a fecal occult blood test to screen for colorectal cancer.
- The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14%.
- In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women. African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country.
- Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost-effective than breast or prostate cancer screening.
FISCAL EFFECT: None
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800 FN: 0000055
Date of Hearing: March 27, 2017
ASSEMBLY COMMITTEE ON RULES
Ken Cooley, Chair
ABPCA Bill Id:ACR 36
Author:(Levine) – As Introduced Ver:March 15, 2017
SUBJECT: Colorectal Cancer Awareness Month
SUMMARY: Designates March 2017 as Colorectal Cancer Awareness Month. Specifically, this resolution makes the following legislative findings:
- Colorectal cancer is the second leading cause of cancer deaths in Californians, with 14,033 new cases and 5,157 deaths observed in 2013. With proper screening, colorectal cancer can be prevented or, if found early, treated and cured.
- According to the United States Preventive Services Task Force, access to appropriate use of colorectal cancer screening tests, such as colonoscopies, sigmoidoscopies, and fecal occult blood tests, could reduce death rates of colon cancer up to 66 percent.
- In 2014, only 55 percent of California adults 50 years of age and older had received a sigmoidoscopy or colonoscopy, and 19 percent had received a fecal occult blood test to screen for colorectal cancer.
- The uninsured, underinsured, and underserved are least likely to get screening for colorectal cancer, which means they are more likely to be diagnosed at a late stage when chances of survival drop to 14 percent.
- In California, colorectal cancer is the most common cancer among Korean and Kampuchean men, the second most common cancer among Hispanic, Japanese, South Asian, and Pacific Islander men, and the second most common cancer among Filipino, Hispanic, Japanese, Korean, Laotian, Vietnamese, and Hmong women. African Americans have the highest colorectal cancer incidence and mortality rates of all racial groups in this country.
- Colorectal cancer screening is one of the most cost-effective prevention measures in health care, more cost-effective than breast or prostate cancer screening.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
California Colorectal Cancer Coalition
Cancer Action Network
Opposition
None on file
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800
Bill Author
Bill Co-Author(s):